Cited by 349Cerebrospinal fluid and hydrocephalusSleep and Wakefulness ResearchTraumatic Brain Injury and Neurovascular Disturbances

The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index; 69 of the 102 sources its claims cite were checked for support.

Norepinephrine-mediated slow vasomotion drives glymphatic clearance during sleep

Open access

Abstract

As the brain transitions from wakefulness to sleep, processing of external information diminishes while restorative processes, such as glymphatic removal of waste products, are activated. Yet, it is not known what drives brain clearance during sleep. We here employed an array of technologies and identified tightly synchronized oscillations in norepinephrine, cerebral blood volume, and cerebrospinal fluid (CSF) as the strongest predictors of glymphatic clearance during NREM sleep. Optogenetic stimulation of the locus coeruleus induced anti-correlated changes in vasomotion and CSF signal. Furthermore, stimulation of arterial oscillations enhanced CSF inflow, demonstrating that vasomotion acts as a pump driving CSF into the brain. On the contrary, the sleep aid zolpidem suppressed norepinephrine oscillations and glymphatic flow, highlighting the critical role of norepinephrine-driven vascular dynamics in brain clearance. Thus, the micro-architectural organization of NREM sleep, driven by norepinephrine fluctuations and vascular dynamics, is a key determinant for glymphatic clearance.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Norepinephrine (NE) oscillations from the locus coeruleus drive slow vasomotion, and these arterial constriction–dilation cycles act as a pump for cerebrospinal fluid (CSF) influx and glymphatic clearance during NREM sleep. The sleep aid zolpidem suppresses NE oscillations and reduces glymphatic tracer influx despite increasing sleep.

Key findings

  • NE and blood albumin signals were anti-correlated across wake, NREM, and REM; blood albumin lagged NE by 0.29±0.6 s in wakefulness and 0.69±0.3 s in NREM sleep. NE oscillation trough-to-peak amplitude was higher in NREM sleep than wakefulness or REM sleep, and NE–blood correlation variability was lower in NREM (SD 0.06) than wake/REM (SD 0.13).
  • Optogenetic locus coeruleus stimulation increased NE and decreased blood albumin in a stimulation-frequency-dependent manner; panadrenergic blockade (PPA) abolished the blood decrease. LC inhibition decreased NE and increased blood albumin. The NE-insensitive GRABNEmut peak during NREM infraslow oscillation was 7.2% of the GRABNE2m peak.
  • CSF tracer was anti-correlated with blood albumin and highest on average in NREM sleep and lowest in REM sleep. LC stimulation increased CSF tracer in a frequency-dependent manner, and this increase was abolished by PPA. NE, blood, and CSF showed phase-locked infraslow oscillations at 0.01–0.02 Hz in NREM sleep (REM: 0.02–0.03 Hz; wake: below ~0.005 Hz).
  • Direct optogenetic stimulation of vascular smooth muscle cells increased vascular oscillation frequency (from 50 s to 10 s period) and enhanced CSF tracer penetration in the stimulated hemisphere in hippocampus and dorsal cortex, but not in ventral surface far from stimulation. Glymphatic clearance correlated negatively with micro-arousal frequency, not with total NREM time, REM time, wake time, NREM delta/theta/sigma/beta power, or wake bouts >20 s. Zolpidem (5 mg/kg) reduced NE oscillation magnitude, decreased baseline prefrontal NE by approximately 50%, increased micro-arousals not associated with NE peaks by ~70%, and lowered glymphatic tracer influx.

Methods

  • Freely behaving mice (wildtype C57BL/6, TH-Cre, Sm22-Cre:Ai32-ChR2 and controls) were used with EEG/EMG, fiber-optic cannula, cisterna magna catheter, and chronic liver-secreted fluorescent albumin labeling. “Flow fiber photometry” combined GRABNE2m NE biosensor, blood albumin, and CSF tracers (3 kDa TMR or FITC dextran) to track NE, vascular, and CSF dynamics across wake, NREM, and REM sleep without head fixation or anesthesia.
  • Optogenetic manipulations targeted locus coeruleus (ChR2 or ArchT) or vascular smooth muscle cells (Sm22-Cre:Ai32-ChR2); pharmacological blockade used prazosin, propranolol, and atipamezole (PPA). Miniscope imaging measured artery/vein diameter and NE; SPECT/CT with intrastriatal [99mTc]-DTPA quantified glymphatic clearance; microdialysis measured prefrontal NE; zolpidem was tested at 5 mg/kg.
  • Analyses included sleep scoring, cross-correlations, power spectral density, time-locking to EEG sigma peaks and micro-arousals, correlation of clearance/influx with sleep parameters, and standard parametric/nonparametric statistics with outlier removal.

Limitations

  • The paper states that hemoglobin absorption may alter the CSF tracer trace during REM sleep, so the study focused on NREM sleep; it also states that REM sleep’s contribution to glymphatic function could not be detected and remains unresolved.
  • The paper states that human confirmation is needed and that it is difficult to know whether zolpidem suppresses NE dynamics in human subjects; it also notes that anesthesia differs from natural sleep and was avoided here.
  • Evident from the text: the causal evidence is mainly from mouse optogenetics and correlational sleep/clearance analyses, with local optogenetic stimulation effects and no direct human glymphatic clearance measurement.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2024.11.027

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

69 of 102 cited sources checked · 23 supported · 1 flagged · accuracy not yet measured

Show all 84 claims

  • Probably not a substantial claim. 24
  • It may state two separate claims as one. 45
64 of 64
  • The paper relies on this without support.

    The brain relies on cerebrospinal fluid circulation through the tissue to remove waste proteins because it lacks lymphatic vessels.

    “Due to the lack of lymphatic vessels, the brain relies on CSF circulation through the tissue to remove waste proteins.”
1 of 1

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Conflicting zolpidem doses for the marble-burying test

    Minor

    The results describe pilot testing at 1 and 5 mg/kg, including the marble-burying test, and the marble-burying method gives those same doses. The drug-preparation method instead says the test used 5 and 10 mg/kg.

  • Baseline microdialysis sample count does not match sampling interval

    Minor

    Samples were obtained every 20 minutes, so a 20-minute baseline would yield one sample, not the stated two.

    Reported 2 · recomputed 1

  • Conflicting SPECT acquisition and reconstruction peak energies

    Minor

    The acquisition specifies a 1200 keV detection peak, whereas reconstruction specifies a photopeak window centered at 140 keV. These are conflicting energies for the stated SPECT photopeak.

3 of 3

Citations

Cites

Flagged first, then by citations

Show all 118 references

Research works printed but not linked: 1

  1. Kanda, 2008, Neurohormonal and metabolic effects of medetomidine compared with xylazine in healthy cats, Can. J. Vet. Res., 72, 278

Cited by

Sorted by citations

Items 201–300 of 349

Metadata

Authors
Hauglund, N. L., Andersen, M., Tokarska, K., Radovanovic, T., Kjaerby, C., Sørensen, F. L., Bojarowska, Z., Untiet, V., Ballestero, S. B., Kolmos, M. G., Weikop, P., Hirase, H., & Nedergaard, M.
Affiliations
University of Copenhagen (DK)
Corresponding author
Nedergaard, Maiken
Venue
Cell
Publisher
Elsevier BV
Published
2025-02
Volume
188
Issue
3
Pages
606-622.e17
ISSN
0092-8674 (ISSN-L)
OpenAlex
W4406155654
Cited by
349
References
118
Citations by year
2026: 229 · 2025: 119
FWCI
186.84
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Simons Foundation (811237)
  • Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  • Independent Research Fund Denmark (0134-00107B, 3101-00282B)
  • Lundbeck Foundation (114955, R386-2021-165)
  • NIH (U19NS128613, AT011439, R01A 012707)
  • EU Joint Programme – Neurodegenerative Disease Research
  • Cure Alzheimer's Fund
  • Novo Nordisk Foundation (NNFOC0058058, NNF23OC0082427, NNF20OC0066419)
  • Human Frontier Science Program (RGP0036)
  • Army Research Office (MURI W911NF1910280)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
Keywords
glymphatic system, norepinephrine, vasomotion, NREM sleep, cerebrospinal fluid flow, cerebral blood volume, locus coeruleus, optogenetic stimulation, zolpidem, brain waste clearance, sleep-dependent memory consolidation
MeSH terms
Zolpidem, Glymphatic System, Animals, Brain, Cerebrospinal Fluid, Cerebrovascular Circulation, Locus Coeruleus, Male, Mice, Inbred C57BL, Norepinephrine, Sleep, Mice, Optogenetics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review